PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer

Conditions:   Cancer-related Fatigue;   Survival;   Tumor, Esophageal
Intervention:   Drug: Astragalus Polysaccharides 500 mg
Sponsor:   PhytoHealth Corporation
Not yet recruiting

https://ift.tt/2v8jdpO